Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Myelofibrosis and RUNX1[original query] |
---|
Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms. Blood 2010 1 115 (14): 2882-90. Thoennissen Nils H, Krug Utz O, Lee Dhong Hyun Tony, Kawamata Norihiko, Iwanski Gabriela B, Lasho Terra, Weiss Tamara, Nowak Daniel, Koren-Michowitz Maya, Kato Motohiro, Sanada Masashi, Shih Lee-Yung, Nagler Arnon, Raynaud Sophie D, Müller-Tidow Carsten, Mesa Ruben, Haferlach Torsten, Gilliland D Gary, Tefferi Ayalew, Ogawa Seishi, Koeffler H Phill |
Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib. Blood 2015 Aug 126 (6): 790-7. Patel Keyur P, Newberry Kate J, Luthra Rajyalakshmi, Jabbour Elias, Pierce Sherry, Cortes Jorge, Singh Rajesh, Mehrotra Meenakshi, Routbort Mark J, Luthra Madan, Manshouri Taghi, Santos Fabio P, Kantarjian Hagop, Verstovsek Srd |
Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up. Annals of hematology 2017 11 97 (3): 443-451. Senín Alicia, Fernández-Rodríguez Concepción, Bellosillo Beatriz, Camacho Laura, Longarón Raquel, Angona Anna, Besses Carles, Álvarez-Larrán Alber |
Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation. European journal of haematology 2019 Aug . Mannina Daniele, Gagelmann Nico, Badbaran Anita, Ditschkowski Markus, Bogdanov Rashit, Robin Marie, Cassinat Bruno, Heuser Michael, Shahswar Rabia, Thol Felicitas, Beelen Dietrich, Kröger Nicola |
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2-mutated neoplasms. Leukemia 2020 12 35 (8): 2371-2381. Todisco Gabriele, Creignou Maria, Gallì Anna, Guglielmelli Paola, Rumi Elisa, Roncador Marco, Rizzo Ettore, Nannya Yasuhito, Pietra Daniela, Elena Chiara, Bono Elisa, Molteni Elisabetta, Rosti Vittorio, Catricalá Silvia, Sarchi Martina, Dimitriou Marios, Ungerstedt Johanna, Vannucchi Alessandro Maria, Hellström-Lindberg Eva, Ogawa Seishi, Cazzola Mario, Malcovati Lu |
Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era. Journal of clinical medicine 2021 Mar 10 (5): . Lee Jong-Mi, Lee Howon, Eom Ki-Seong, Lee Sung-Eun, Kim Myungshin, Kim Yongg |
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 2023 9 13 (1): 149. Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M Patna |
[Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 6 44 (4): 276-283. X Yan, T J Qin, B Li, S Q Qu, L J Pan, F H Li, N N Liu, Z J Xiao, Z F |
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms. British journal of haematology 2023 5 . Mark Gurney, Ismahene Chekkaf, Anmol Baranwal, Rami Basmaci, Bahga Katamesh, Patricia Greipp, James M Foran, Talha Badar, Abhishek A Mangaonkar, Kebede H Begna, Naseema Gangat, Mrinal M Patnaik, Mark R Litzow, Mithun V Shah, David S Viswanatha, Rong He, Hassan B Alkhateeb, Aref Al-Ka |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: